ATE247672T1 - Zusammensetzung und diese enthaltende pharmazeutische zubereitung für die behandlung von herpes und verwandten viralen infektionen - Google Patents
Zusammensetzung und diese enthaltende pharmazeutische zubereitung für die behandlung von herpes und verwandten viralen infektionenInfo
- Publication number
- ATE247672T1 ATE247672T1 AT98943613T AT98943613T ATE247672T1 AT E247672 T1 ATE247672 T1 AT E247672T1 AT 98943613 T AT98943613 T AT 98943613T AT 98943613 T AT98943613 T AT 98943613T AT E247672 T1 ATE247672 T1 AT E247672T1
- Authority
- AT
- Austria
- Prior art keywords
- accordance
- present
- treatment
- mammals
- discovered
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 8
- 238000011282 treatment Methods 0.000 title abstract 5
- 208000036142 Viral infection Diseases 0.000 title abstract 2
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 title 1
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
- 241000124008 Mammalia Species 0.000 abstract 6
- 241000700605 Viruses Species 0.000 abstract 5
- 239000003795 chemical substances by application Substances 0.000 abstract 4
- 230000000120 cytopathologic effect Effects 0.000 abstract 4
- 244000179560 Prunella vulgaris Species 0.000 abstract 3
- 235000010674 Prunella vulgaris Nutrition 0.000 abstract 3
- 238000000034 method Methods 0.000 abstract 3
- 239000000284 extract Substances 0.000 abstract 2
- 238000000746 purification Methods 0.000 abstract 2
- 239000013543 active substance Substances 0.000 abstract 1
- 230000000840 anti-viral effect Effects 0.000 abstract 1
- 239000002246 antineoplastic agent Substances 0.000 abstract 1
- 238000012512 characterization method Methods 0.000 abstract 1
- 229940127089 cytotoxic agent Drugs 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 238000000605 extraction Methods 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 230000001506 immunosuppresive effect Effects 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
- 230000009385 viral infection Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/536—Prunella or Brunella (selfheal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0003—General processes for their isolation or fractionation, e.g. purification or extraction from biomass
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Public Health (AREA)
- Polymers & Plastics (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Materials Engineering (AREA)
- Mycology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Sustainable Development (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US5977597P | 1997-09-23 | 1997-09-23 | |
| PCT/CA1998/000891 WO1999015566A1 (en) | 1997-09-23 | 1998-09-23 | Composition and pharmaceutical preparation containing same for the treatment of herpes and related viral infections |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE247672T1 true ATE247672T1 (de) | 2003-09-15 |
Family
ID=22025139
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT98943613T ATE247672T1 (de) | 1997-09-23 | 1998-09-23 | Zusammensetzung und diese enthaltende pharmazeutische zubereitung für die behandlung von herpes und verwandten viralen infektionen |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP1017727B1 (de) |
| JP (1) | JP2001517715A (de) |
| KR (1) | KR20010030700A (de) |
| CN (1) | CN1116306C (de) |
| AT (1) | ATE247672T1 (de) |
| AU (1) | AU9150198A (de) |
| BR (1) | BR9812388A (de) |
| CA (1) | CA2304136A1 (de) |
| DE (1) | DE69817381D1 (de) |
| NZ (1) | NZ503622A (de) |
| WO (1) | WO1999015566A1 (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6811600B2 (en) | 2003-01-23 | 2004-11-02 | Engelhard Corporation | Chemically bulked kaolin clay pigment compatible with calcium carbonate and manufacture thereof |
| CN1965894B (zh) * | 2006-05-12 | 2010-06-02 | 上海中医药大学 | 一种具免疫活性的夏枯草多糖组合物及其制备方法和应用 |
| CN107865828B (zh) * | 2016-09-24 | 2020-03-27 | 上海中医药大学附属曙光医院 | 防治结肠癌转移的口服结肠定位制剂、制备方法及其应用 |
| CN111748045B (zh) * | 2019-03-27 | 2022-01-07 | 天津医科大学 | 亨氏马尾藻岩藻聚糖硫酸酯制备方法及应用 |
| CN113476497B (zh) * | 2021-05-12 | 2022-07-01 | 上海中医药大学 | 一种具有抗hsv活性的夏枯草提取物及其制备方法和医药用途 |
| CN113244243A (zh) * | 2021-06-09 | 2021-08-13 | 暨南大学 | 齐墩果酸在制备治疗疱疹性脑炎药物的用途 |
| CN118731201A (zh) * | 2024-06-03 | 2024-10-01 | 广东永顺生物制药股份有限公司 | 一种对猪伪狂犬病病毒gD和/或gB蛋白的HPLC定量检测方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5411733A (en) * | 1992-04-27 | 1995-05-02 | Hozumi; Toyoharu | Antiviral agent containing crude drug |
| CN1081375A (zh) * | 1993-06-23 | 1994-02-02 | 李联放 | 一种抗血栓药物的制备方法及用途 |
| JPH07291815A (ja) * | 1994-04-26 | 1995-11-07 | Meiji Milk Prod Co Ltd | 植物ウイルス病防除剤 |
| JP4019128B2 (ja) * | 1995-11-21 | 2007-12-12 | 生化学工業株式会社 | 抗ヘルペスウイルス剤 |
| AU4995597A (en) * | 1996-10-23 | 1998-05-15 | Vertex Pharmaceuticals Incorporated | Methods of using sucrose octasulfate to treat or prevent enveloped virus infection |
-
1998
- 1998-09-23 EP EP98943613A patent/EP1017727B1/de not_active Expired - Lifetime
- 1998-09-23 AU AU91501/98A patent/AU9150198A/en not_active Abandoned
- 1998-09-23 CA CA002304136A patent/CA2304136A1/en not_active Abandoned
- 1998-09-23 WO PCT/CA1998/000891 patent/WO1999015566A1/en not_active Ceased
- 1998-09-23 CN CN98811423A patent/CN1116306C/zh not_active Expired - Fee Related
- 1998-09-23 BR BR9812388-2A patent/BR9812388A/pt not_active IP Right Cessation
- 1998-09-23 KR KR1020007003141A patent/KR20010030700A/ko not_active Withdrawn
- 1998-09-23 AT AT98943613T patent/ATE247672T1/de not_active IP Right Cessation
- 1998-09-23 NZ NZ503622A patent/NZ503622A/en unknown
- 1998-09-23 DE DE69817381T patent/DE69817381D1/de not_active Expired - Lifetime
- 1998-09-23 JP JP2000512869A patent/JP2001517715A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| DE69817381D1 (de) | 2003-09-25 |
| KR20010030700A (ko) | 2001-04-16 |
| CN1116306C (zh) | 2003-07-30 |
| CA2304136A1 (en) | 1999-04-01 |
| NZ503622A (en) | 2002-02-01 |
| WO1999015566A1 (en) | 1999-04-01 |
| JP2001517715A (ja) | 2001-10-09 |
| BR9812388A (pt) | 2000-09-12 |
| EP1017727B1 (de) | 2003-08-20 |
| EP1017727A1 (de) | 2000-07-12 |
| AU9150198A (en) | 1999-04-12 |
| CN1297455A (zh) | 2001-05-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA199901031A1 (ru) | Производные бензимидазола | |
| UA66744C2 (en) | 5,6-dichlorobenzimidazole derivatives, methods for the preparation thereof, pharmaceutical composition and method for treatment of viral infections | |
| EP0270317A3 (de) | Pharmaceutische Zuberatung zur Behandlung von Virus-Krankheiten | |
| ES541103A0 (es) | Procedimiento de obtencion de una composicion para el trata-miento de infecciones virales | |
| BRPI0414045A (pt) | administração de ligantes de tlr7 e pró-medicamentos dos mesmos para tratamento de infecção por vìrus de hepatite c | |
| FI20001231A7 (fi) | 2-Deoksi-2,3-didehydro-N-asetyylineuramiinihapon johdannaisia ja niiden analogeja ja niiden käyttö antiviraalisina aineina | |
| ATE231839T1 (de) | Polyaromatische antivirale zusammensetzungen | |
| GEP20084497B (en) | Hiv protease inhibitors | |
| MX9304837A (es) | Peptidos capaces de inhibir la actividad de proteasa vih, su preparacion y su uso terapeutico. | |
| BG100829A (bg) | Бензотиофен, бензофуран и индолтиазепинони, оксазепинони и диазепинони като инхибитори на клетъчна адхезия и на нiv | |
| ATE247672T1 (de) | Zusammensetzung und diese enthaltende pharmazeutische zubereitung für die behandlung von herpes und verwandten viralen infektionen | |
| MX9805441A (es) | Compuestos terapeuticos. | |
| EP0426785A4 (en) | Compositions and methods for treating viral infections | |
| TR200102024T2 (tr) | Yeni tedavi. | |
| ES8608884A1 (es) | Un procedimiento de eliminacion del virus lav. | |
| ES2105923A1 (es) | Composiciones para el tratamiento de una infeccion y una enfermedad causadas por el virus de la hepatitis b (hbv). | |
| HUP0203050A2 (hu) | Endometriózis és meddőség kezelésére, valamint a termékenység fokozására alkalmas gyógyszerkészítmények | |
| ATE302011T1 (de) | PONAZURIL ZUR BEHANDLUNG VON DURCH COCCIDIA NEUROLOGISCHEN UND ßABORTIGENICß VERURSACHTEN ERKRANKUNGEN | |
| ATE310521T1 (de) | Praziquantel zusammensetzungen zur behandlung von krankheiten verursacht durch kokzidien | |
| DK0685235T3 (da) | Ekstrakter af Piliostigma thonningii, anvendelse heraf og formuleringer, som indeholder dem | |
| EP0428105A3 (en) | Prevention of glycoprotein enveloped virus infectivity by quinolyl- and isoquinolyloxazole-2-ones | |
| EP0335426A3 (en) | Compositions and process for protecting t lymphocytes against the etiological agent of lymphadenopathy and acquired immunodepression syndrom | |
| MY101495A (en) | Treatment of diseases caused by viruses | |
| TW217986B (en) | Compositions for the treatment of infection and disease caused by HBV | |
| CA2193665A1 (en) | Benzimidazole derivatives for the treatment and prophylaxis of virus infections |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |